Curcumin and other plant polyphenols appear to act through mechanisms involving the regulation of intestinal receptors, such as TLR4, and the modulation of the intestinal barrier, suggesting that treatment with these compounds could represent a promising therapeutic strategy to counteract gut–brain axis dysfunctions, particularly in conditions of obesity. Here, TLR4 is linked to obesity due to melanocortin 4 receptor deficiency.